BETA-1,3'-GALACTOSYLLACTOSE FOR THE TREATMENT OF GUT BARRIER FUNCTION DISEASES
Application
US20260083764A1
Kind: A1
Mar 26, 2026
Assignee
N.V. Nutricia
Inventors
Saskia Braber, Belinda Potappel - van 't Land, Selma Paulien Wiertsema, Johan Garssen, Bernd Stahl, Marko Mank
Abstract
The invention relates to the use of beta1,3′-galactosyllactose for improving the gut barrier function. This can in particular be administered to subjects at risk for increased gut barrier permeability, preferably infants and young children.
CPC Classifications
A61K 31/702
A23L 29/04
A23L 29/30
A23L 33/12
A23L 33/125
A23L 33/17
A23L 33/40
Filing Date
2025-11-24
Application No.
19398141